header logo image


Page 1,043«..1020..1,0421,0431,0441,045..1,0501,060..»

Biotechnology Summer Courses – Reach Cambridge

May 9th, 2017 8:43 pm

The Reach Cambridge Biotechnology course introduces students to both the academic study of biotechnology and its exciting practical applications in the real world. This fast-growing area of modern science has the potential to fundamentally alter how we produce food, treat disease and create medicines. Topics covered include genetics, drug resistance, pharmaceutical science, biotechnological devices and drug design. Through lectures by experts in the field and hands-on practical sessions, students will be offered a unique insight into both the study of biotechnology at university and the vocational opportunities in the field beyond higher education.

This exciting and dynamic course will be a rewarding program for all those who have a passionate interest in biotechnology and biological sciences. During the Scholar program, the Biotechnology course is academically intensive and intellectually challenging, focused on the complex scientific problems which the discipline is in the process of tackling.

All Reach Cambridge courses are open to students aged between 14-18 years old.

All courses are taught in English. In order to get the most out of the learning experience, students are advised to have a level of English conducive to understanding sophisticated academic language and to converse with other students and staff in English at all times.

We do offer English as Second Language courses if you, or we, feel that this is more appropriate. Your personal statement will help indicate to us your level of English. We will also ask for a copy of your latest school transcript to help us assess the teaching level of the courses.

Originally posted here:
Biotechnology Summer Courses - Reach Cambridge

Read More...

BioTech Jobs in the BioTechnology Pharmaceuticals Industry

May 9th, 2017 8:43 pm

1 - 15 of 6,981 jobs

Global Personnel Search Inc

Columbus, OH

Analytical ScientistColumbus, OHPosition Description:This Ph.D. Analytical Scientist (R&D) position will be responsible for leading the project from feasibility phase to commercial launch. We are...

posted 1 day ago

Bio Partners Search Group, LLC

Northern, Nj, NJ

The Associate Director, Commercial Analytics is responsible for supporting Marketing/Sales and Managed Care Markets Management in the following key areas: physician targeting, segmentation, sample...

posted 1 day ago

KOB Solutions, Inc.

Paramus, NJ

My client is actively recruiting for a Director of Clinical Operations to develop the internal infrastructure of this growing firm and oversee clinical trials operations. The ideal candidate will...

posted 1 day ago

Gallin Associates

Norristown, PA

Job Profile:Manager to oversee major key manufacturing transfer programs for a world class medical device manufacturer. The position will be responsible for managing the transfer of manufacturing...

posted 1 day ago

Med Exec Intl / MEIRxRS

Los Angeles, CA

VP Clinical & Regulatory Affairs needed in Los Angeles, CAVP Clinical and Regulatory Affairsneeded to develop and implement clinical studies and molecular diagnostics validation strategy. The...

posted 1 day ago

CHLOETA

Boise, ID

CHLOETA is a dynamic incident management firm that conducts and plans operations nationwide for a variety of public and private sector clients. Incident Management Team (IMT) ReservistAs an IMT...

posted 1 day ago

Regency Search Group

South Bend, IN

Company BackgroundFor 30 years, this research laboratory has been manufacturing and distributing a variety of enzymes and cofactors used in basic coagulation research. They are known and trusted by

posted 1 day ago

Spark Therapeutics, Inc

Philadelphia, PA

Individual with strong pharmacology and toxicology experience in developing AAV-based therapies. The candidate will be responsible for the strategy and execution of pharmacology and toxicology...

posted 2 days ago

Stabilis Professional Services

Andover, MA

Stabilis Professional Services, Inc. is looking for aBioinformatics Software Developer for their client in Andover, MA.Responsibilities: Designs, codes, tests, corrects and documents moderately...

posted 2 days ago

Excelsior Recruiting Group

New York, NY

BENEFITSCompetitive base starting at 90k plus commissionExcellent Benefits packageCompany CarGreat Growth Opportunity!!!QUALIFICATIONS Minimum of 10 years of sales & project experience in packaging

posted 3 days ago

Spark Therapeutics, Inc

Philadelphia, PA

The Research Scientist is a member of the Liver Discovery Research functional group within the Discovery Research group under Translational Research. He/she will be responsible for: Design and...

posted 4 days ago

Continental Search and Outplacement, Inc.

Indianapolis, IN

Leading company in animal agriculture seeks experienced sales professional to grow their market share in Indiana, Ohio and northern Kentucky. Candidates can live anywhere within the region andwork...

posted 4 days ago

Philadelphia, PA

The Assay Development Associate - Vector Shedding/Bio Distribution will: With guidance and supervision from the group leader or supervisor, conduct clinical and preclinical sample analysis per SOPs...

posted 4 days ago

Spark Therapeutics, Inc

Philadelphia, PA

The Sr. Regulatory Operations Specialist contributes to daily operations activities for preparation of regulatory submissions to FDA, EMA, and other key health authorities. They also collaborate...

posted 4 days ago

Spark Therapeutics, Inc

Philadelphia, PA

The Head of Medical Science Liaisons (MSL) will be responsible for helping to build and lead Spark MSL team(s). This position will define the objectives of the MSL function, including building...

posted 4 days ago

Originally posted here:
BioTech Jobs in the BioTechnology Pharmaceuticals Industry

Read More...

J&J discloses US probe related to arthritis drugs – Reuters

May 9th, 2017 8:42 pm

Healthcare conglomerate Johnson & Johnson said on Monday the U.S. Justice Department has opened an investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that bought two of its drugs.

The U.S. healthcare company said its Janssen Biotech Inc unit received a civil investigative demand from the Justice Department regarding an investigation under the False Claims Act related to its arthritis drugs Remicade and Simponi Aria.

J&J also revealed in its quarterly filing that the U.S. Attorney's Office in Massachusetts is seeking documents broadly relating to pharmaceutical co-payment support programs for hepatitis C drug Olysiotm, Simponi and Crohn's disease drug Stelara. (bit.ly/2qUhznX)

That office's subpoena also seeks documents relating toaverage manufacturer price and best price reporting to the Center for Medicare and Medicaid services related to those products, as well as rebate payments to state Medicaid agencies, Johnson & Johnson said in the filing.

(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Bill Trott)

WASHINGTON The U.S. economy will fall short of the Trump administration's goal of 3 percent growth this year and will only achieve that when its regulatory, tax, trade and energy policies are fully in place, Commerce Secretary Wilbur Ross said on Tuesday.

News Corp reported better-than-expected quarterly revenue as the owner of the Dow Jones Newswires and the Wall Street Journal saw an uptick in its digital real estate business and growth in its advertising revenue.

A decline in subscribers and higher programming costs at cash-cow ESPN weighed on shares of Walt Disney Co on Tuesday, overshadowing a quarterly profit that topped Wall Street estimates.

See the rest here:
J&J discloses US probe related to arthritis drugs - Reuters

Read More...

Arthritis in the hands more common than you might think, study says – Wichita Eagle

May 9th, 2017 8:42 pm
Arthritis in the hands more common than you might think, study says
Wichita Eagle
Arthritis in the hands is more common than you might think. Nearly 1 in 2 women and 1 in 4 men will develop the condition in their lifetime, according to a new study. The risk of symptomatic hand osteoarthritis also varies by race and weight. Aching or ...

Link:
Arthritis in the hands more common than you might think, study says - Wichita Eagle

Read More...

Survey reveals impact of arthritis on mental health – The Irish News – the Irish News

May 9th, 2017 8:42 pm

the Irish News
Survey reveals impact of arthritis on mental health - The Irish News
the Irish News
A survey released by Arthritis Care reveals the hidden impact that living with arthritis has on people's mental wellbeing. Of those surveyed in Northern Ireland 83 ...
Survey unveils 'enormous hidden impact' arthritis has on mental ...ITV News
Fundraising dinner success for Arthritis Care | News | Tenby ObserverTenby Observer

all 4 news articles »

Read the rest here:
Survey reveals impact of arthritis on mental health - The Irish News - the Irish News

Read More...

Stem cells therapy for naturally occurring intervertebral disc disease – Medical Xpress

May 9th, 2017 8:41 pm

May 9, 2017 Credit: Vetsuisse Faculty, UZH

The intervertebral disc is the "shock absorber" between the vertebrae of the spine, cushioning every step, bend and jump. If the fibrocartilage tissue in the spine degenerates over time, an intervertebral disc can "slip" pinching the medulla or nerves. The consequences include intense pain or even paralysis. Dogs and people are often susceptible to this disease. Since intervertebral discs themselves cannot regenerate, the affected disc material is removed in an operation that can be performed on both people and animals. The pressure on the nerves and medulla disappears, but the degeneration of the disc remains.

Frank Steffen, neurologist at the Clinic for Small Animal Surgery at the Vetsuisse Faculty of the University of Zurich, has developed a stem cell therapy for the condition. Stem cells are multipotent cells that can be differentiated into various cell types. Steffen hopes that the stem cells will possibly form new disc cartilage once injected into a damaged disc. His study on three sick German shepherds demonstrate that treatment with the body's own stem cells is well tolerated an important first step.

Gaining knowledge directly from the afflicted animal

Research on intervertebral disc regeneration is frequently performed using animal testing. At the Clinic for Small Animal Surgery in Zurich, researchers have taken another path: "Since we treat numerous dogs who spontaneously sustain a slipped disc every year, we have been able to gain important knowledge directly from animals that are actually afflicted with this disease," Steffen explains. "Due to the similarity in pathology and the course of the illness, conclusions can presumably be drawn for the treatment of affected persons as well." The project for the development of stem cell therapy in dogs is being conducted in cooperation with Swiss Paraplegic Research (SPR) in Nottwil, Switzerland.

With the permission of the dog owners, Steffen and his team removed stem cells from the marrow of the pelvic bone of the affected animals. After the cleaning and preparation of the cell material in the laboratory, the stem cells were injected into the degenerated intervertebral disc during an operation. "Our objective is for the stem cells to trigger cellular and molecular repair processes and, ideally, to form new intervertebral disc cells in order to contribute to the regeneration of the tissue," Steffen says.

After tolerability, check effectiveness

The results are promising: The three dogs tolerated the injections of their own stem cells and the researchers have determined no negative effects. However, later X-rays and magnetic resonance tomographies did not show clear indications that the damaged discs have regenerated in comparison with the control group.

Steffen says, "Proving the tolerability of the therapy was our first important step." Now, he is working on the effectiveness of the stem cell injections with the targeted addition of growth factors. "If our method proves successful one day, it would be a pioneering step for human medicine as well," the neurologist says.

Explore further: MRI can visualize effects of traction on herniated discs

More information: Frank Steffen et al. Bone Marrow-Derived Mesenchymal Stem Cells as Autologous Therapy in Dogs with Naturally Occurring Intervertebral Disc Disease: Feasibility, Safety and Preliminary Results, Tissue Engineering Part C: Methods (2017). DOI: 10.1089/ten.TEC.2017.0033

Certain blood vessels in the brainstem constrict when blood vessels elsewhere in the body would dilate. And that contrary behavior is what keeps us breathing, according to a new paper by UConn researchers published May 8 ...

Engineers at the University of California San Diego have developed biomimetic bone tissues that could one day provide new bone marrow for patients needing transplants.

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new technique that uses modified insulin and red blood cells to create a glucose-responsive "smart" insulin ...

New research from Boston Children's Hospital and Beth Israel Deaconess Medical Center (BIDMC) shows that chronic sleep loss increases pain sensitivity. It suggests that chronic pain sufferers can get relief by getting more ...

A team of researchers at Cambridge has identified how areas of the brain govern both our emotions and our heart activity, helping explain why people with depression or anxiety have an increased risk of cardiovascular disease.

An international study led by researchers at Monash University' Biomedicine Discovery Institute (BDI) has shone light on the way the Hepatitis C Virus (HCV) hijacks the communication systems in the host cells it infects, ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read the original here:
Stem cells therapy for naturally occurring intervertebral disc disease - Medical Xpress

Read More...

College of Optometry researchers fight myopia, blindness – The Daily Cougar

May 8th, 2017 6:46 pm

Myopia exists when light focuses in front of the retina, rather than on top of it. | Courtesy of David Gee/College of Optometry

The University of Houstons College of Optometry is leading the charge in the fight against myopia, or nearsightedness, with several studies aimed at discovering how to fully stop the progression of the condition in children a problem that can lead to permanent blindness.

Dr. Earl Smith, Dean of the UH College of Optometry, wasnamed one of the Most Influential in Optometryin 2015 for his extensive research into myopia and was recently awarded a $1.9 million research grant by the National Eye Institute to help fund hisongoing work. Dr. David Berntsen is part of a clinical trial for childrens contact lenses that builds off of some of Smiths work, and Dr. Ruth Manny worked on two studies that tested eyeglasses and looked for myopia risk factors.

Were in the middle of an epidemic of myopia, Smith said. In Asia, East Asia, for example: Japan, Hong Kong, Taiwan, Singapore if you look at the kids graduating from technical high schools in urban areas, 80 to 95 percent are nearsighted, and theyre not a little bit nearsighted. Theyre a lot nearsighted.

Myopia exists when the eye grows too long on its axial length, Smith said, so light from a faraway object focuses in front of the retina, rather than on it. This causes objects at large distances to look blurry.

The myopia epidemic, Smith said, is likely caused by intense educational practices and lack of time outside for children. Sitting indoors, reading and studying for long hours does not give the eye enough variety in distance or exposure to sunlight. Everything inside is close to the eye, Smith said, while everything outside is far away, giving the eye the needed signal to slow growth.

Myopia is one of the largest causes of permanent blindness in Asia, he said, and the condition is taking hold in the United States. From 1970 to 2000, the number of myopia sufferers in the adult population jumped from to 45 percent from 25 percent. Those with severe myopia increased by a factor of eight, Smith said.

An estimated five billion people half of the earths population will be nearsighted by 2050 if nothing is done about the epidemic, Smith said. One billion of those five billion people will have severe myopia, Smith said, which is likely to lead to permanent blindness.

Glasses and contact lenses are the most common ways to correct nearsightedness, Smith said, because they changethe focus of the light received by the eye so that it comes to rest on the retina.

Smith said the goal of his research is to understand the role of vision in affecting eye growth. The eye has corrective systems in place so that during development, if vision is blurry, the eye will grow to correct it.

At first, Smith said, his research was focused on those suffering from lazy or crossed eyes. His focus shifted once he foundthat visual experience plays a key role in the development of those conditions and myopia.

Vision regulates the way the eye grows, whether one is nearsighted or not, Smith said. Its a fascinating thing. The eye uses visual feedback associated with defocus to regulate the way the eye grows. Because of changes in our behavior, those systems sometimes operate in ways that cause the eye to become nearsighted.

Smith said the biggest contribution his research made was proving that the periphery vision could dominate eye growth. If corrective bifocal contact lenses are applied, giving the wearer clear vision while simultaneously correcting the peripheral vision, eye growth will be slowed and myopia can be avoided, Smith said.

Dr. David Berntsen,an associate professor at the College of Optometry and fellow recipient of funding from the National Institutes of Health, is working on the Bifocal Lenses In Nearsighted Kids clinical trial.

My funding and the primary work in my lab is clinical trials in kids, looking at specific types of lenses to see if they can slow myopia progression, Berntsen said.

The funding Berntsen received is a different type of grant system that funds large-scale clinical trials, he said. The BLINK study is a collaboration between UH researchers and colleagues at Ohio State University.

BLINK enrolled about 150 kids at UH and 144 at Ohio State University, aged 7 to 11-years-old, over the course of about a year and a half, Berntsen said.

Berntsen explained that each child is randomly assigned one of three kinds of contact lenses. The control lens is one that is normally prescribed to correct myopia.The other two are bifocals with varying degrees of plus-power in the periphery of the lens focusing the light sooner at the edges, controlling eye growth according to the findings of Smiths research.The peripheral light is then focused in front of the retina, which sends a signal to the eye to slow growth.

Traditional lenses give the wearer clear central vision, but peripheral light focuses behind the retina, which may stimulate the eye to grow longer,which exacerbates myopia, Berntsen.

Corrective lenses are the standard of care for treating myopia, Berntsen said, so there are no studies comparing myopic progression with lenses versus no lenses.There are studies that have found that peripheral light focused behind the retina like with traditional spectacles is associated with faster progression than when peripheral light is focused in front of the retina,like with Berntsens bifocal contacts.

Berntsen said the ultimate goal of his research is to stop eye growth in myopic children, but currently it can only be slowed.

Another College of Optometry professor, Dr. Ruth Manny, was involved in a similar study in 2008. The Correction of Myopia Evaluation Trialaimed to understand differences in the progression of myopia in children wearing different types of eyeglasses.

The question COMET was designed to answer was: Is the increase in nearsightedness that occurs as children get older different between children who wear eyeglasses with progressive additional bifocals (no line bifocal) and children who wear conventional single vision spectacle lenses? Manny said in an email.

There were 469 children enrolled in four different cities: Houston, Boston, Philadelphia and Birmingham, Alabama. Manny said that after three years of study, researchers found that while myopia progression was less in those children wearing bifocals, the difference was too small to recommend no-line bifocals as a method to treat myopic children.

The results of COMET have led researchers to explore different treatments, Manny said, such as the bifocal contact lenses in Berntsens study.

Manny was also involved in a study called theCollaborative Longitudinal Evaluation of Ethnicity and Refractive Errorthat looked at 13 risk factors for myopia in children, and found that refractive error, orlight focusing incorrectly within the eye, was the single best predictor of the condition.

Despite working within the same college at UH, Smith, Berntsen and Manny are not directly involved in each others research, they explained.

[emailprotected]

Tags: College of Optometry, myopia, nearsightedness, optometry, research, UH College of Optometry

Does the construction along Spur 5, which will eventually impact the U.S. 59 north and south on-ramps from I-45, affect your commute to class?

Total Voters: 106

Read the original here:
College of Optometry researchers fight myopia, blindness - The Daily Cougar

Read More...

Women face higher risk of blindness than men – Marianas Variety

May 8th, 2017 6:46 pm

(Press Release) Studies show there is a gender gap in eye disease. Women are more likely than men to suffer from sight-threatening conditions such as age-related macular degeneration, cataracts, and glaucoma.

In support of Healthy Vision Month in May, Marianas Eye Institute and the American Academy of Ophthalmology remind women to make vision a top priority.

Women make up 65 percent of macular degeneration cases; 61 percent of glaucoma and cataract patients are women, and 66 percent of blind patients are women. Why the inequity? There are a few theories. On average women live longer and many eye problems are age-related. Some eye conditions, such as dry eye, are more common in women, young and old. Social and economic factors affect womens access to eye care, especially in developing countries.

Whatever the cause, there are a few unique vision problems women need to watch out for more than men. Dry eye occurs at double the rate in postmenopausal women. In general, women are more susceptible to autoimmune diseases than men, many of which affect vision, such as lupus, Sjogrens syndrome and hyperthyroidism. Also, pregnancy can cause vision changes due to the hormones pregnant women experience.

Good news is most vision loss is preventable. Marianas Eye Institute and the academy offers five simple steps to take control of your eye health today:

Get a comprehensive medical eye exam at age 40. Early signs of disease or changes in vision may begin at this age. An exam by one of Marianas Eye Institutes specialists is an opportunity to carefully examine the eye for diseases and conditions that may have no symptoms in the early stages.

Know your family history. Certain eye diseases can be inherited. If you have a close relative with macular degeneration, you have a 50 percent chance of developing this condition. A family history of glaucoma increases your glaucoma risk by four to nine times. Talk to family members about their eye conditions. It can help you and your eye specialist evaluate your risk.

Eat healthy foods. A diet low in fat and rich in fruits, vegetables, and whole grains, benefits the entire body, including the eyes. Eye-healthy food choices include citrus fruits, vegetable oils, nuts, whole grains, dark green leafy vegetables and cold water fish.

Stop smoking. Smoking increases the risk for eye diseases such as cataract and age-related macular degeneration. Smoking also raises the risk for cardiovascular diseases which can indirectly influence your eye health. Tobacco smoke, including second-hand smoke, also worsens dry eye.

Wear sunglasses. Exposure to ultraviolet UV light raises the risk of eye diseases, including cataract, fleshy growths on the eye and cancer. Always wear sunglasses with 100 percent UV protection and a hat while enjoying time outdoors.

Eye exams arent only about checking a persons visual acuity or sharpness, but also determining the overall health of their eyes, said Rebecca J. Taylor, M.D., clinical spokesperson for the American Academy of Ophthalmology. We encourage women as well as men to get regular eye care. By making vision a priority today, we can help protect our sight as we age.

We know that women in the CNMI drive most of their familys healthcare decisions. They are often the leaders in their families, said Russ Quinn, CEO of Marianas Eye Institute. Yet the statistics clearly show that women are at higher risk for eye disease, and we encourage them all the CNMIs women to make sure their own care receives priority, he said.

To learn more ways to keep your eyes healthy, visit the Marianas Eye Institute website.

Marianas Eye Institute is known as a regional leader in eye care, providing total eye care for the family, including express glasses, contact lenses, medical eye care, surgery and laser. Marianas Eye Institute is staffed by Dr. Dennis Williams, who has been listed in Americas Top Ophthalmologists, and Dr. Mark Robertson, a magna cum laude optometrist, along with eight other highly talented and nationally certified eye care ophthalmic technicians, opticians, and contact lens technicians. Located on Beach Road in Garapan, across 13 Fishermen Monument, Marianas Eye Institute is open Monday through Saturday and accepts new patients as well as walk-ins. Anyone interested in womens eye health can call 235-9090.

Read more from the original source:
Women face higher risk of blindness than men - Marianas Variety

Read More...

ETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain – Barron’s

May 8th, 2017 6:46 pm

Barron's
ETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain
Barron's
Meanwhile the SPDR S&P Biotech ETF (XBI), the SPDR S&P Pharmaceuticals ETF (XPH), and the First Trust NYSE Arca Biotechnology Index (FBT) fell about 2.7% apiece. The AHCA could have both positive and negative impact on pharma and biotech, but ...

Follow this link:
ETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain - Barron's

Read More...

Puma Biotechnology Stock Slumps as Regulatory VP Departs Before FDA Review – Los Angeles Business Journal

May 8th, 2017 6:46 pm

Puma Biotechnology Inc.s stock took a dive last week after its regulatory executive resigned less than three weeks before a U.S. Food and Drug Administration panel is scheduled to review the public companys breast cancer drug Neratinib.

The Westwood companys share price dipped 14 percent to $31.38 at the close of business May 5 from $36.45 the day before, when the company notified the Securities and Exchange Commission that Robert Charnas, senior vice president of regulatory affairs and project management, would step down for health reasons effective May 15.

The stock was trading at $29.15 when the markets closed Monday.

The company, which has a market cap of $1.07 billion, hired 63-year-old Charnas last year with a base salary of more than $330,000, stock options, and a more than $378,000 signing bonus, according to the employment offer letter filed with the SEC.

An independent panel of experts is scheduled to review Neratinib for safety and efficacy May 24 before making a recommendation for its use to the FDA.

Caroline Anderson is a staff reporter covering retail, restaurants, and hospitality. She can be reached at canderson@labusinessjournal.com.

More here:
Puma Biotechnology Stock Slumps as Regulatory VP Departs Before FDA Review - Los Angeles Business Journal

Read More...

Animal Biotechnology Technologies, Markets and Companies 2016 … – PR Newswire (press release)

May 8th, 2017 6:46 pm

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture.

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine.

Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.

Approximately 124 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

Share of biotechnology-based products and services in 2016 is analyzed and the market is projected to 2026.

The text is supplemented with 35 tables and 5 figures.Selected 260 references from the literature are appended.

Key Topics Covered:

Executive Summary

1. Introduction to Animal Biotechnology

2. Application of Biotechnology in Animals

3. A Biotechnology Perspective of Animals Diseases

4. Molecular Diagnostics in Animals

5. Biotechnology-based Veterinary Medicine

6. Research in Animal Biotechnology

7. Animal Biotechnology Markets

8. Regulatory issues

9. Companies Involved in Animal Biotechnology

10. References

For more information about this report visit http://www.researchandmarkets.com/research/mdr33b/animal

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/animal-biotechnology-technologies-markets-and-companies-2016-2026-with-profiles-of-the-top-companies---research-and-markets-300452977.html

SOURCE Research and Markets

http://www.researchandmarkets.com

Original post:
Animal Biotechnology Technologies, Markets and Companies 2016 ... - PR Newswire (press release)

Read More...

Puma Biotechnology Inc (PBYI) Plunges 5.54% on May 08 – Equities.com

May 8th, 2017 6:46 pm

Market Summary Follow

Puma Biotechnology Inc is a A biopharmaceutical company

PBYI - Market Data & News

PBYI - Stock Valuation Report

Puma Biotechnology Inc (PBYI) had a rough trading day for Monday May 08 as shares tumbled 5.54%, or a loss of $-1.7 per share, to close at $29.00. After opening the day at $30.45, shares of Puma Biotechnology Inc traded as high as $31.20 and as low as $28.50. Volume was 1.11 million shares over 8,212 trades, against an average daily volume of 941,762 shares and a total float of 36.97 million.

As a result of the decline, Puma Biotechnology Inc now has a market cap of $1.07 billion. In the last year, shares of Puma Biotechnology Inc have traded between a range of $73.27 and $19.74, and its 50-day SMA is currently $38.11 and 200-day SMA is $43.37.

For a complete fundamental analysis of Puma Biotechnology Inc, check out Equities.coms Stock Valuation Analysis report for PBYI.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investments Market Commentary and Adam Sarhans Find Leading Stocks today.

Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care.

Puma Biotechnology Inc is based out of Los Angeles, CA and has some 160 employees. Its CEO is Alan H. Auerbach.

Puma Biotechnology Inc is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Puma Biotechnology Inc and to follow the companys latest updates, you can visit the companys profile page here: PBYIs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

See the rest here:
Puma Biotechnology Inc (PBYI) Plunges 5.54% on May 08 - Equities.com

Read More...

The Charts Expose On Puma Biotechnology, Inc. (PBYI) Is Causing A Stir – NY Stock News

May 8th, 2017 6:46 pm

NY Stock News
The Charts Expose On Puma Biotechnology, Inc. (PBYI) Is Causing A Stir
NY Stock News
The technicals for Puma Biotechnology, Inc. (PBYI) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup. Reading the technical chart for a given stock is a ...

See more here:
The Charts Expose On Puma Biotechnology, Inc. (PBYI) Is Causing A Stir - NY Stock News

Read More...

Puma Biotechnology, Inc. Posted losses of -16.01% in the Last … – Free Observer

May 8th, 2017 6:46 pm

Puma Biotechnology, Inc. (PBYI) belongs to the Healthcare sector with an industry focus on Biotechnology, with Mr. Alan H. Auerbach as Founder, Chairman, Chief Exec. Officer, Pres and Sec..

The company has been one of the biggest innovators in Biotechnology.

Key Statistics:

Financials:

The company reported an impressive total revenue of 0 in the last fiscal year.

If you look at the companys income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, PBYI earned gross profit of 0, in 2015 0 gross profit, while in 2016 Puma Biotechnology, Inc. (PBYI) produced 0 profit.

Currently the shares of Puma Biotechnology, Inc. (PBYI) has a trading volume of 4.25 Million shares, with an average trading volume of 1220 shares with shares dropping to a 52 week low of $19.74, and the companys shares hitting a 52 week high of $ 73.27.

Looking at the current price of the stock and the 52 week high and low, it suggests that the stock is likely to go Up in the future.

Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for Puma Biotechnology, Inc. the EPS stands at -2.04 for the previous quarter, while the analysts predicted the EPS of the stock to be -1.92, suggesting the stock fell short of the analysts expectations.

Another critical number in evaluating a stock is P/E or the price to earnings ratio.

The TTM operating margin is 0%. The return on invested capital at 0%, which is good, compared to its peers.

The Free Cash Flow or FCF margin is 0%.

Stock is currently moving with a negative distance from the 200 day simple moving average of approximately -29.35%, and has a solid year to date (YTD) performance of 0% which means the stock is constantly adding to its value from the previous fiscal year end price.

Future Expectations:

The target price for Puma Biotechnology, Inc. (PBYI) is $79/share according to the consensus of analysts working on the stock, with an expected EPS of $-1.98/share for the current quarter.

Read more:
Puma Biotechnology, Inc. Posted losses of -16.01% in the Last ... - Free Observer

Read More...

Arthritis forum to hear benefits of physical activity – Forfar Dispatch

May 8th, 2017 6:45 pm

Angus patients living with arthritis are invited to a free information session which will focus on the benefits of physical activity for those living with arthritis.

Visiting speaker, Dr Kathryn Martin from the University of Aberdeen will lead the session discussing why physical activity should be prescribed for people living with arthritis and will give tips for optimal arthritis management.

The topic has been chosen given the increasing evidence to support activity as one of the most important lifestyle interventions for both arthritis and chronic pain, with additional positive benefits to mental health and wellbeing.

Dr Martin leads a programme of research focused on physical activity, arthritis, musculoskeletal conditions and ageing.

The meeting will take place on Wednesday, June 7, from 6.30 to 8.30pm in the Lintrathen Room, Whitehills Health and Community Care Centre.

Refreshments will be available and those attending are very welcome to bring a friend or family member along with them. No booking is required.

The arthritis forum aims to provide adults living with any type of arthritis in Angus with access to ongoing and up to date information about their condition and its management as well as providing people with the chance to meet with others also living with arthritis.

The group was established to support people to live well with arthritis and, as well as providing information, the meeting offers a chance to chat with others living with arthritis over a cup of tea or coffee.

The meetings are organised by Angus Health & Social Care Partnership in partnership with the local Arthritis Forum.

For more information or to be added to the mailing list to receive advance notice about further meetings, please contact the Primary Care Team on 01307 474889 or email achppatientcourses.tayside@nhs.net.

Read more here:
Arthritis forum to hear benefits of physical activity - Forfar Dispatch

Read More...

Dr Mark Porter: Stiff knees may not be a sign of arthritis, just that you need to do some exercise – The Times (subscription)

May 8th, 2017 6:45 pm

Creaky, stiff knees are a common problem in the over-40s. Yet while they are often the first sign of underlying arthritis they are not, as is often thought, the beginning of a journey that inevitably ends in surgery or joint replacement. At least they may not be if you heed aching joints as a warning sign and are prepared to do a bit of hard work.

Most people think of osteoarthritis as a one-way wear-and-tear process related to overuse, but it is also the bodys response to injury and part of a process designed to try to repair the joint. Some people with early osteoarthritis do get progressively worse and end up needing surgery, but a similar proportion remain stable as far as symptoms are

Link:
Dr Mark Porter: Stiff knees may not be a sign of arthritis, just that you need to do some exercise - The Times (subscription)

Read More...

Health Beat with Dr. Alicia Arnold: Arthritis Help – WEAU

May 8th, 2017 6:45 pm

EAU CLAIRE, Wis. (WEAU) -- Arthritis in seniors is no joking matter. Thats why Dr. Alicia Arnold talked to Courtney Everett about things older Americans can do around the home to help ease the pain. Their question and answer can be found below and you can watch the video above to learn more.

Dr. Alicia Arnold, The most common kind of arthritis in seniors is osteoarthritis, also called degenerative joint disease. Normally we have cartilage protecting our joints by acting as a cushion in between our bones. In osteoarthritis, our cartilage breaks down, resulting in pain and swelling. Osteoarthritis is most common in people older than 65. About half of people will get knee arthritis in their lives, and about 1 in 12 seniors have hand arthritis.

Arthritis is known for being painful.

Dr. Alicia Arnold, Arthritis is known for being uncomfortable, but one of the best ways to manage osteoarthritis is by staying active. Building muscles and stay flexible can help you be more comfortable. You can find ways to adjust your movements, such as pushing open doors with your shoulder or the sides of your arms.

Lets look at a few items youve brought in that may be helpful to anyone suffering from arthritis. Wed like to say thank you to Synergy Home Care, who contributed some of the ideas for these hacks.

Drinking glassesone lightweight and bumpy for gripping, --one with rubber band around it for grip

Gardening gloves with rubber coating to help open jars.

Foam hair roller over knife handle to help improve grip.

Round key rings or bobby pins or a paper clip through zipper pulls to help gripping zippers easier

Upside down ice cube tray to hold playing cards

Coffee mugpick your coffee mug up with two hands instead of using the handle. Similarly, pick a milk or juice jug up with both hands instead of using the handle.

Toilet cleaner tabletsanything you can use for pre-cleaning, like these automatic toilet bowl cleaner tablets or daily shower cleaner will lessen the amount you have to scrub and be easier on your joints

Scissorshaving scissors around will help you avoid ripping things open like a plastic bag or packet

Talk to us about arthritis and falls.

Dr. Alicia Arnold, Elderly adults with arthritis are more likely to have a fall injury than those without arthritis. Common places to fall include the bathroom and stairs. Slippery surfaces in the bathroom cause many falls. Grab bars and nonslip mats are helpful for the bathroom and you can consider using brightly colored tape along the edges of stairs to help seniors judge the distance and depth of the steps. You can also consider adding a second railing to the other side of the stairs to give seniors something else to hold onto.

See the original post:
Health Beat with Dr. Alicia Arnold: Arthritis Help - WEAU

Read More...

Arthritis sufferer hopes to raise awareness about local services – Sarnia Observer

May 8th, 2017 6:45 pm

Amanda Hay knows firsthand the value of arthritis research.

The 30-year-old Sombra woman who was diagnosed with rheumatoid arthritis at age eight spent most of her childhood in a wheelchair until a new experimental drug became available.

After more than a decade in a wheelchair due to pain, Hay decided to take a chance on Enbrel, a biologic medicine that blocks the immune system from sending out signals that cause joint inflammation.

Within two weeks I was walking, said Hay, who had been forced to give up figure skating and other physical activities due to the pain she was experiencing.

Hay credits scientific advancements along with the support of her family and the Arthritis Society for helping her live a normal life.

More than two decades after her diagnosis, Hay works full-time and has learned to manage her debilitating pain through rest and exercise.

It's challenging, she said. I'm lucky enough that my company is supportive because I've educated them on my daily limits.

Hay hopes to raise more awareness about the chronic condition by hosting Sarnia-Lambton's first Walk to Fight Arthritis next month.

The fundraising walk with one-kilometre and five-kilometre route options is planned for June 4 at the Sombra ball park on Duke Street. Gates open at 9:30 a.m., with the walk slated to begin at 10:30 a.m.

Proceeds from the walk will benefit The Arthritis Society, a non-profit that funds research and provides local services out of Sarnia's Community Care Access Centre.

Those services include physical and occupational therapies, social work services and chronic pain management workshops.

Hay was inspired in part to host a local walk out of a desire to raise awareness about the local services provided by the Arthritis Society.

While Sarnia has never had its own Arthritis Society office, Hay said she's still been able to access services through the society, like a youth summer camp for young arthritis sufferers.

They're very willing to help anybody, she said.

More than 4.6 million Canadians aged 15 years and older currently report living with arthritis, according to The Arthritis Society. By 2036, it's estimated that one in every five Canadian adults will have arthritis.

But the debilitating joint-attacking condition can also impact the lives of children.

At age eight Hay was diagnosed with rheumatoid arthritis a type of inflammatory arthritis that can cause swelling and pain in the hands and wrists through to the knees and feet after she went numb on the left side of her body overnight.

Right away (the doctor) said, 'She has rheumatoid arthritis,' Hay recalled. My mom said, 'That's impossible. Kids don't have arthritis.'

But Hay's parents soon accepted the diagnosis and started working with their daughter to improve her quality of life.

I've been lucky that my parents pushed me when I was younger to do my therapy and wear my splints, said Hay, who eventually had to undergo orthopedic surgery to get staples in her growth plate.

As a child, Hay served as a local spokesperson for The Arthritis Society, but she didn't reconnect with the non-profit again until a few years ago when she started participating in London's annual Walk To Fight Arthritis.

In 2016, Hay was named the top fundraiser for the London walk, collecting $5,000 for the charity from family, friends and a few local companies.

That's when she was approached about starting a Sarnia-area walk because she and a small group of fellow arthritis sufferers were travelling from Lambton County annually to raise dollars in London.

She immediately saw the value in hosting a local Walk to Fight Arthritis an event that has connected her with other arthritis survivors and served as inspiration for her to continue her own fight with the condition.

It's made me look at my case and say, 'I'm not as bad off as others.'

To register for the walk either as a participant or a volunteer Hay can be contacted at sarniawalktofightarthritis@arthritis.ca or at 519-402-3832.

bsimpson@postmedia.com

--- --- ---

IF YOU GO

What: Walk to Fight Arthritis

When: June 4. Gates open at 9:30 a.m. Walk starts at 10:30 a.m.

Where: Sombra ball park, Duke Street

Continued here:
Arthritis sufferer hopes to raise awareness about local services - Sarnia Observer

Read More...

My husband’s heart failure inspired a life-saving stem cell therapy – Telegraph.co.uk

May 8th, 2017 6:45 pm

Its our goal for this to be a normal NHS procedure, so everyone who has a heart problem [and could benefit from this] will be able to. There are few downsides because theres no rejection as theyre your own stem cells, and every patient who has successfully had this treatment ends up taking less medication.

Jenifer is overjoyed with the progress already made, and knows that Ian would be, too, had he lived to tell his story.

For Ian, the treatment gave him an extra three years of life, but in 2006 he died from heart failure, at the age of 70.

He would be so thrilled, says Jenifer. His concern would be were not doing it quick enough, because for him everything had to be done immediately. But to have achieved this much well, the medical world says weve done it all in a very short space of time.

The couple spent their final years together alternating between their family home in St Johns Wood, north London, and a holiday home in Miami.

They were both each others second spouses, having married in 1980 after a whirlwind romance in Cannes Jenifers first husband had died, while Ian had divorced his wife and did not have children together. But Ian had two children from his first marriage, as well as two young grandchildren who he was able to spend those extra three years with.

Read more from the original source:
My husband's heart failure inspired a life-saving stem cell therapy - Telegraph.co.uk

Read More...

Dr. Nathan Newman’s Stem Cell Lift Helps Women Get Their Sex Life Back! – Business Wire (press release)

May 8th, 2017 6:45 pm

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Stem cell therapy is revolutionizing medicine and now has come to the rescue once again, this time, to help those who suffer from a debilitating, auto-immune skin disease called Lichen Sclerosus (LS). For most patients, this condition attacks the genitalia causing unbearable burning and itching, as well as making sexual intercourse very painful and impossible for some. Severe symptoms can interfere with activities such as exercising, sitting for extended periods of time, or even wearing tight clothing. Previously reported that LS only occurs in post-menopausal women, recent reports, however, state that as many as one in 30 people may suffer from LS and yet, the information on this disease is sparse and relief is hard to find. To date, there is no known cure for this painful disease, which can also affect men and children.

The tragedy of Lichen Sclerosus, says Board Certified Dermatologist, Nathan Newman, M.D. of Beverly Hills, CA is that it often goes unrecognized for years and is frequently misdiagnosed as a post-menopausal change, a yeast infection, urinary tract infection or even a venereal disease, such as herpes. Until now, the main treatment for LS has been topical potent steroids to alleviate the symptoms. However, many patients report no symptomatic relief from conventional treatments and some even experience an exacerbation of symptoms.

Now, with the Stem Cell Lift developed by Dr. Newman, there is hope for these patients for not only relief of their symptoms, but also to help prevent disease progression. Dr. Newman, a well-known pioneer in stem cell therapy, developed his proprietary Stem Cell Lift over 16 years ago for post-cancer reconstruction, wound healing and the innovative, natural, scar-free, knife-free rejuvenating face lift. During this procedure, fat is removed from your own body and the stem cells found in this fat are concentrated and injected back into the treatment area. Stem cells are specialized cells that are genetically programmed to help repair, restore and replenish damaged cells and tissues in our body. Through my experience and knowledge of stem cell therapy, explains Dr. Newman, I knew that stem cells have been able to positively affect the immune response and put other auto-immune diseases in remission.

He applied his knowledge of stem cell therapy to treating patients suffering from LS with the Stem Cell Lift and is finding success in helping to alleviate the symptoms of Lichen Sclerosus. In fact, the first patient he treated for LS with the Stem Cell Lift has been in remission for almost four years.

Anna, a 56-year-old woman diagnosed two years ago with LS says, The fusing, burning and tearing were so painful, I couldnt sit down. Topical steroids were not providing her relief from her painful symptoms. After her first Stem Cell Lift treatment, Anna is thrilled to report she is experiencing 91-100% relief from her debilitating symptoms. ANNA VIDEO

To date, I have treated more than 150 patients with Lichen Sclerosus with the Stem Cell Lift, states Dr. Newman. Remarkably, 25% of these patients are in complete remission; meaning they have no symptoms and no disease progression. Most describe significant improvement in symptoms, are no longer using any topical steroids and do not have any anatomical changes. Patients report they can resume their normal activities, such as exercising, wearing jeans or underwear and are able to have intercourse without discomfort.

He adds, My staff and I are in constant contact with our Lichen Sclerosus patients to monitor their progress and to study the effectiveness of the Stem Cell Lift. Although all of his patients have reported significant overall improvement in their symptoms, most patients require 2-3 treatments to achieve optimal benefits. Dr. Newman continues, The Stem Cell Lift is showing very promising results in bringing relief to Lichen Sclerosus sufferers. Our hope is it will continue to result in remission of LS.

After discovering how little information is available to those who suffer from LS, Dr. Newman is dedicated to raising more awareness about it and is determined to help those suffering from this horrible disease. To achieve this personal mission, he is launching a campaign called #LS HOPE: Helping Open Peoples Eyes to Lichen Sclerosus in May 2017. His dream is to create an annual LS HOPE month every May.

For more information on Dr. Nathan Newman and his treatment of Lichen Sclerosus, please visit his website http://stem-cell-lift.com/ and LS link http://stem-cell-lift.com/lichen-sclerosus/ that includes videos of patient testimonials. Dr. Newman is located at 9301 Wilshire Boulevard, Beverly Hills, CA and can be reached at 310-273-3344.

Links to patient testimonials TRACI VIDEO LAURIE VIDEO

Here is the original post:
Dr. Nathan Newman's Stem Cell Lift Helps Women Get Their Sex Life Back! - Business Wire (press release)

Read More...

Page 1,043«..1020..1,0421,0431,0441,045..1,0501,060..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick